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Comparison of adhesion and virulence of two predominant
hospital-acquired MRSA clones and clonal MSSA isolates
Abstract
The virulence of SCCmec type IV HA-MRSA clinical isolates belonging to the major sequence type
ST8 (Lyon clone) and to a minor upcoming clone ST5, was compared with that of MSSA isolates of
matching sequence types. In vitro adhesion to human airway epithelial cells (HAEC), as an indicator of
dissemination, and mortality in a murine sepsis model, as an indicator of virulence, were evaluated. Ten
MRSA and 8 MSSA of ST8, and 8 MRSA and 8 MSSA of ST5 were characterized with respect to
MLST, agr, spa and capsule typing, in vitro doubling time, toxin and adhesin gene profiles and
adherence to HAEC. Adherence was significantly lower in MRSA ST5 than in the ST8 groups.
Infections with MRSA and MSSA isolates ST8 or ST5 were compared. No change in virulence related
to the presence of SCCmec was observed, since ST8 but not ST5 caused a significantly lower mortality
in its presence. Despite their similar genetic background individual clonal MRSA and MSSA isolates
were heterogeneous in adherence and virulence. No one of these specific virulence factors determined in
vitro was related to mouse mortality. In conclusion, in a bacteraemic model, mortality was dependent on
the ST and was differentially modulated by SCCmec; within a ST, clonality was not associated with a
homogenous outcome.
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The virulence of SCCmec type IV hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA)
clinical isolates belonging to the major sequence type 8 (ST8 [Lyon clone]) and to a minor upcoming clone,
ST5, was compared with that of methicillin-susceptible S. aureus (MSSA) isolates of matching sequence types.
In vitro adhesion to human airway epithelial cells (HAECs) as an indicator of dissemination and mortality in
a murine sepsis model as an indicator of virulence were evaluated. Ten MRSA isolates and 8 MSSA isolates
of ST8 and 8 MRSA isolates and 8 MSSA isolates of ST5 were characterized with respect to multilocus
sequence type; agr, spa, and capsule typing; in vitro doubling time; toxin and adhesin gene profiles; and
adherence to HAECs. Adherence was significantly lower in the MRSA ST5 group than in the ST8 groups.
Infections with MRSA and MSSA isolates ST8 and ST5 were compared. No change in virulence related to the
presence of SCCmec was observed, since ST8 but not ST5 caused a significantly lower mortality in its presence.
Despite their similar genetic backgrounds, individual clonal MRSA and MSSA isolates were heterogeneous in
adherence and virulence. No one of these specific virulence factors determined in vitro was related to mouse
mortality. In conclusion, in a bacteremic model, mortality was dependent on the ST and was differentially
modulated by SCCmec; within an ST, clonality was not associated with a homogenous outcome.
Staphylococcus aureus is a pathogen expressing multiple viru-
lence factors such as adhesins, toxins, and immune evasion mol-
ecules that enable the bacteria to induce a wide variety of infec-
tions. Hospital-acquired (HA) methicillin-resistant S. aureus
(MRSA) arose in 1961 through the acquisition of the SCCmec
element and has become one of the most frequent pathogens
responsible for HA infections worldwide, particularly in intensive
care units (ICUs). Molecular characterization by multilocus se-
quence typing (MLST) of clinical MRSA isolates in a given area
revealed that most are genetically related by sharing the same
sequence type (ST), belong to one of the five major clonal com-
plexes (CC), and disseminate within and between hospitals. We
recently described and genetically characterized the HA-MRSA
isolates detected in France (6). The major clone (Lyon clone)
shares ST8, which belongs to CC8; a second clone shares ST5,
which belongs to CC5 and is related to the New York-Japan clone
and has been spreading for a few years.
Differences in pathogenicity and virulence between MRSA
and methicillin-susceptible S. aureus (MSSA) isolates may exist
but remain an unresolved question. Studies of MRSA viru-
lence in humans suggest a greater burden for MRSA infections
in terms of length of hospitalization and mortality rate, but
these studies are impaired by multiple confounding factors (5,
21). First, differences in patient populations with respect to
comorbidities and therapeutic options that are more or less
bactericidal limit conclusions about a putative association be-
tween increased virulence and methicillin resistance. Second,
pandemic MRSA clones may have specific virulence proper-
ties, as has been demonstrated for the pandemic MRSA clone
in Brazil (CC8, ST239), which has an enhanced ability to ad-
here to and invade epithelial cells in vitro compared with
sporadic MRSA isolates (3).
This study used the two major HA-MRSA clones, MRSA
ST8 and ST5, detected in France and isolates of MSSA with
either ST8 or ST5 to evaluate (i) adhesion to human airway
epithelial cells (HAECs) as an indicator of dissemination and
(ii) mortality rates induced in a murine sepsis model as an
indicator of virulence. We compared the mortality rates after
infection with MRSA and MSSA, both belonging to ST8 and
ST5, to determine the effect of SCCmec and ST on virulence.
To define the role of SCCmec in an isogenic background, we
included an MRSA ST30 isolate from which SCCmec was
cured. Finally we related epithelial cell adhesion and in vitro
virulence properties to the mortality induced by different iso-
lates of a given lineage.
MATERIALS AND METHODS
S. aureus isolates. During a survey in ICUs of Edouard Herriot Hospital (a
1,100-bed University Hospital located in Lyon, France), we collected 17 MRSA
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isolates responsible for bloodstream infections representing two different MRSA
clones (11). The major one called, the Lyon clone, comprised 13 of the 17
isolates, which shared the agr type 1 allele, ST8, CC8, spa type t008 or relatives,
and SCCmec type IV and were positive for the staphylococcal enterotoxin A
(sea) gene. The minor clone, related to the New York-Japan clone, was found in
3 of the 17 isolates, which shared the agr type 2 allele, ST5, CC5, spa type t002
or relatives, and SCCmec type IV and were positive for the tst gene and the egc
locus. Epidemiological studies revealed that the Lyon clone was the predominant
MRSA clone in France, whereas the ST5 MRSA clone was emergent and has
been spreading throughout France for some years (6, 9). For this study, we
randomly selected 10 of the 13 MRSA ST8 Lyon clone isolates and the 3 MRSA
ST5 isolates positive for the tst gene and the egc locus. To analyze the effect of
the SCCmec cassette on adhesion and virulence, we completed the first strain
selection by adding eight MSSA ST8 and eight MSSA ST5 isolates, also origi-
nating from bloodstream infections. The isolates either were collected by the
National Center for Staphylococci located in Lyon, France, during a national
survey (in 2006 to 2007) or were spontaneously referred to the Center (in the
period 2003 to 2007). Five MRSA ST5 isolates were taken from a national survey
to complete the first selection of three MRSA ST5 isolates. Thus, the study
included 10 MRSA and 8 MSSA isolates of ST8 and 8 MRSA and 8 MSSA
isolates of ST5. Finally, we used as an isogenic control pair an MRSA ST30
isolate (WSPPA) and its isogenic mutant from which SCCmec was cured
(ME230) (2, 20).
Characterization of the genetic background and virulence factors. All strains
were characterized by MLST, spa typing, and accessory gene regulator (agr)
allele typing as previously described (1–4). Capsular typing was based on sero-
typing and PCR as previously described (22). Each isolate was genetically char-
acterized by adhesin gene profiling (fnbA and fnbB [encoding fibronectin binding
proteins A and B, respectively], clfA and clfB [encoding clumping factors A and
B, respectively], eno [encoding laminin binding protein], ebpS [encoding elastin
binding protein], cna [encoding collagen binding protein], and bbp [encoding
bone sialoprotein binding protein]), and toxin gene content (tst; staphylococcal
enterotoxins and enterotoxin-like sea, seb, sec, sed, seh, selK, selL, selM, selO, selP,
selQ, and selR) with multiplex PCR (13, 14). Positive isolates for selM and selO
were considered to be also positive for the egc locus, since these genes belong to
the egc operon. Delta-toxin production was determined in an agar plate assay
testing synergy with a beta-toxin reference strain as previously described; isolates
without delta-toxin production were considered to have dysfunction of the agr
locus (19). Production of alpha-toxin was determined by incubating the strains
overnight on sheep blood agar plates at 37°C. Superantigen expression was
measured by using Ridascreen set A, B, C, D, and E (R-Biopharm AG, Darm-
stadt, Germany).
Doubling time. Bacterial doubling time was determined as previously de-
scribed, with minor modifications (10). Overnight cultures were diluted 1:100 in
5 ml of brain heart infusion (BHI) medium and grown on for 3 h at 37°C and 180
rpm. These cultures were seeded at a 1:100 dilution and a 1:4 culture/flask ratio
and then incubated at 37°C and 180 rpm for further 4 h. Optical density was
measured every 30 min for 4 h. Values were converted into log2 values, and the
doubling time was calculated as the reciprocal of the slope.
Determination of adhesion to HAECs. Adhesion to HAECs was analyzed as
previously described (7). Experiments were performed in triplicates, and the
number of adherent bacteria per cell was averaged for at least 30 cells per strain.
Determination of virulence in a murine sepsis model. Female C57BL/6 and
BALB/c mice, 6 to 8 weeks old, were maintained under specific-pathogen-free
conditions in the Animal House of the Department of Biomedicine, University
Hospital Basel, Switzerland. All experiments were performed in accordance with
the Swiss Veterinary Law. Before intravenous challenge, S. aureus isolates were
grown freshly from frozen stock cultures (70°C) prepared using the Microbank
(Basel, Switzerland) system (Pro Lab Microbank bacterial preservation system
green). One cryoculture bead per strain was incubated in 1 ml of BHI broth
(BBL Becton Dickinson, MD) for 7 h at 37°C. Cultures were then diluted 1:100
in 5 ml of BHI broth and incubated overnight at 37°C. Bacteria were then
centrifuged at 4,000  g for 10 min, and the pellet was washed twice and
resuspended in pyrogen-free 0.9% NaCl before use. Mice were injected with
MRSA and MSSA inocula ranging from 5.1  107 to 1.4  108 CFU (median)
in a volume of 200 l via the caudal vein. The median inocula were as follows:
MRSA ST8, 1.4  108 CFU; MSSA ST8, 6.8  107 CFU; MRSA ST5, 6.8  107
CFU; and MSSA ST5, 5.1  107 CFU. The median inocula for MRSA ST30
WSPPA and ME230 were 3  107 CFU in C57BL/6 mice and 3  106 CFU in
BALB/c mice. A further subgroup of 15 BALB/c mice were infected with MRSA
ST8 at a median inoculum of 2.8  106 CFU. Control mice were injected with
200 l of 0.9% saline. Weight change and clinical severity were determined 1, 2,
5, and 8 days after infection. Disease severity was assessed by the following
scoring system: 0, normal activity; 1, trembling and weakness; 2, piloerection and
decreased activity; 3, constrained movements and strongly decreased activity;
and 4, no movement. The mice were sacrificed by intraperitoneal injection of 100
mg/kg pentobarbital (Abbott Laboratories) when they reached a score of 4, and
surviving mice were sacrificed on day 8 after infection. Four to five mice per
group were used.
Data analysis. Data were analyzed with SPSS and Graph Pad Prism 4 software.
Categorical data were analyzed with Fisher’s exact test. Continuous variables
were compared using the Mann-Whitney U test for two groups and with the
Kruskall Wallis test for more than two groups. P values of0.05 were considered
to denote statistical significance. Survival differences between mice challenged
with the different groups were analyzed during the infection process with the log
rank test and a Kaplan-Meier survival curve. Overall mortality after infection was
determined by chi-square contingency test.
RESULTS
Adhesion of ST8 and ST5 isolates to HAECs. MRSA and
MSSA, each of ST8 and ST5, respectively, representing the
prevalent clones in French ICUs, were first compared in their
adherence to HAECs. Adherence was widely variable in
MRSA ST8 and in MSSA ST8 (Fig. 1). The median value was
significantly lower for MRSA ST5 than for both MRSA ST8
(P  0.001) and MSSA ST8 (P  0.05) but was similar to that
of MSSA ST5. The median adhesion of all ST5 isolates
(MRSA and MSSA) was significantly lower than that of all ST8
isolates (P  0.0002 [data not shown]).
Effect of the SCCmec cassette on virulence in ST8 and ST5
lineages. MRSA and MSSA isolates of the same ST were then
used to infect C57BL/6 mice, and the mortality rates were
determined. When comparing genetically similar strains differ-
ing with respect to the presence or absence of SCCmec, it was
evident that SCCmec had a variable influence upon outcome
depending on the ST lineage. As a group, MRSA ST8 induced
a lower mortality than MSSA ST8 (Fig. 2A). Conversely,
MRSA ST5 induced a higher mortality than MSSA ST5 (Fig.
2B). Thus, we may conclude that the observed high mortality of
MRSA ST5 was not related to SCCmec, since both MRSA ST5
and MRSA ST8 isolates have this determinant but only MRSA
ST5 induced a higher mortality than its SCCmec counter-
parts. This conclusion was corroborated by survival studies
with an MRSA ST30 isolate and its isogenic mutant, from
which SCCmec was cured. C57BL/6 and BALB/c mice infected
with either strain showed similar rates of mortality (data not
shown).
Virulence of individual isolates of ST8 and ST5 lineages.
Mortality was analyzed for each group of mice infected with
FIG. 1. Adherence of 10 MRSA ST8 (closed circles), 8 MRSA ST8
(closed squares), 8 MSSA ST8 (open circles), and 8 MSSA ST5 (open
squares) isolates to human airway epithelial cells. Statistical signifi-
cance by analysis of variance: MRSA ST8 versus MRSA ST5, P 
0.001; MRSA ST8 versus MSSA ST 5, P 0.05; and MRSA ST5 versus
MSSA ST8, P  0.05. ns, not significant.
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the different isolates of each lineage. Results obtained with
both ST8 (Fig. 3) and ST5 (Fig. 4) strains with and without
SCCmec showed a similar, striking variability of mortality rates
between the isolates of any given ST. Three of the 10 isolates
belonging to MRSA ST8 were never lethal, whereas 7 were
lethal for 50 to 100% of the mice. Similarly, for MSSA ST8 the
mortality rate varied from 20% with one strain to 100% with
four strains (Fig. 3). Among MRSA ST5, which as a group was
most virulent, only one isolate was lethal for 20% of the mice
and seven isolates were lethal for 50 to 100% of the mice.
Finally, MSSA ST5 contained two nonlethal and three 100%
lethal isolates among eight strains.
To find an explanation for the variable mortality of geneti-
cally related strains, the in vitro growth, adhesion to HAECs,
adhesin and toxin gene profiles, as well as toxin production of
MRSA ST8 and MRSA ST5 were related to the outcome as
presented in Fig. 3 and 4. The doubling times of all groups of
strains were similar: 31.00 2.67 min and 26.50 3.87 min for
MRSA ST8 and MRSA ST5, respectively; and 26.50  3.87
min and 30.5  1.35 for MSSA ST8 and MSSA ST5, respec-
tively. Isolates belonging to the ST8 and ST5 groups harbored
capsular type 5. Comparison of the adhesion gene profiles
revealed that MRSA and MSSA of both ST8 and ST5 har-
bored the fnbA, fnbB, clfA, clfB, and eno genes, with one
exception in the MSSA ST8 group, which lacked fnbA. Fur-
thermore, all ST8 isolates harbored the sea gene and all ST5
isolates harbored the tst and ebpS genes and the egc locus. As
shown in Fig. 3 and 4, no specific virulence factor was able to
discriminate between lethal and nonlethal ST8 or ST5 isolates.
In particular, the three nonlethal isolates of MRSA ST8 (Fig.
3) and the two nonlethal isolates of MSSA ST5 (Fig. 4) did not
differ in adhesin and toxin expression from their lethal coun-
terparts. To evaluate the role of tst for mortality in the ST5
isolates, a group of four mice was infected with the isogenic tst
deletion mutant of MRSA ST5 isolate HT 2003-0749. The
mortality induced by the tst deletion mutant was even higher
(50% [data not shown]) than that of isolates expressing tst
(20% for isolate HT 2003-0749 [Fig. 4]). This is in agreement
with the observation that tst suppresses exoprotein expression
(23).
Effect of host genotype on outcome after infection with
MRSA ST8. To exclude that differences in lethality between
MRSA ST8 isolates were solely visible in the C57BL/6 strain,
we infected the more susceptible inbred mouse strain BALB/c
with 8 of the same 10 MRSA ST8 isolates. Five of seven strains
which were highly virulent in C57BL/6 mice were also the most
virulent strains in BALB/c mice, and the three isolates which
were nonlethal in C57BL/6 mice (Fig. 3) were also the least
virulent strains in BALB/c mice. Mortality in BALB/c mice was
significantly higher for lethal than for nonlethal MRSA, as
determined in C57BL/6 mice (80% versus 33%; P  0.0445
[data not shown]).
DISCUSSION
In this study, we have demonstrated that while MRSA and
MSSA ST8 isolates displayed similar adhesion to HAECs in
vitro, the MRSA ST8 isolates collectively exhibited a lower
virulence than the MSSA isolates in a murine sepsis model.
Conversely, the minor MRSA ST5 clone in France exhibited
low adhesion to HAECs in vitro and displayed significantly
greater lethality in the sepsis model than MSSA ST5 isolates.
The mechanism involved in the selection of pandemic
MRSA clones is not clear. The worldwide dissemination of
MRSA clones may be dependent on particular adhesive prop-
erties that enable bacterial colonization of mucosal and skin
surfaces. Indeed, Amaral et al. showed that adhesion to a
bronchial epithelial cell line of the Brazilian MRSA pandemic
clone was higher than that of sporadic MRSA and clinical
MSSA isolates (3). In contrast, Aathithan et al. found similar
adhesion to the liver epithelial cell line HepG2 when compar-
ing two pandemic MRSA clones in the United Kingdom with
the MSSA strains Wood 46 and Cowan I (1). Our study is the
first to compare levels of adhesion of genetically similar groups
of clinical MRSA and MSSA isolates to primary human airway
epithelia. We found generally lower adhesion in lineage 5 than
8 and the lowest values for the MRSA ST5 group. The latter
was not explained by a different adhesin gene profile. Future
investigations on adhesin protein expression of MRSA ST5
FIG. 2. (A) Survival of 44 and 41 mice infected with 10 MRSA ST8 isolates (closed circles) and 8 MSSA ST8 isolates (open circles), respectively.
P  0.0012 by log rank test in Kaplan-Meier analysis. Four to five mice were infected with each strain. (B) Survival of 42 and 32 mice infected with
eight MRSA ST5 isolates (closed squares) and eight MSSA ST5 isolates (open squares), respectively. P  0.001 by log rank test in Kaplan-Meier
analysis. Four to five mice were infected with each strain.
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and blockade of adhesin receptors on airway epithelial cells
will help link ST and dissemination.
Dissemination of pandemic MRSA clones would not be a
problem per se if S. aureus would not be such a virulent bac-
terium. To assess the contribution of SCCmec to virulence, we
performed studies with genetically closely related strains of the
ST8 and ST5 lineages with and without SCCmec by using a
well-defined sepsis model in inbred mice.
In this model, the MRSA ST8 clone isolates killed fewer
mice than the MSSA ST8 isolates. This supports the previous
results of Mizobuchi et al., who compared the virulence of 13
highly resistant MRSA isolates and 7 MSSA isolates from
patients with various clinical syndromes (17) and found that
MRSA isolates were less virulent than MSSA. However, it
should be noted that the strains in the above mentioned study
were not genetically characterized. Peacock et al. found that a
strain belonging to an epidemic MRSA clone showed similar
lethality to three clinically significant MSSA strains after intra-
peritoneal or intravenous inoculation of mice (18). Our com-
parative study of MRSA and MSSA infection in mice is
strengthened by the genetic homogeneity of the MSSA isolates
and their genetic similarity to the MRSA isolates. Since our
MRSA ST5 and MSSA ST8 isolates were equivalently virulent,
we can conclude that acquisition of SCCmec type IV per se is
not associated with a loss of virulence. Furthermore, our in
vivo results complemented our in vitro growth data showing
that clonal MRSA and MSSA isolates of either ST8 or ST5 had
similar doubling times. It is possible that a potential initial
fitness burden (15) due to SCCmec acquisition was overcome
by compensatory mutations. It is also possible that only those
clones survived which, despite acquisition of resistance, re-
tained rapid growth (4, 16). To draw a clear conclusion regard-
ing the effect of SCCmec upon virulence, sepsis was induced
with an MRSA ST30 isolate and its isogenic mutant, from
which SCCmec was cured. Results from these experiments
support our conclusion that SCCmec per se has no effect on
virulence, since in both mouse strains C57BL/6 and BALB/c,
the survival rates of mice infected with the wild-type and mu-
tant isolates were similar.
When investigating virulence factors, which could contribute
FIG. 3. Individual genotypic and phenotypic characteristics of the MRSA and MSSA ST8 isolates.
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to lethal outcome, MRSA and MSSA isolates with a homoge-
neous genetic background as determined by methods de-
scribed in this current study, had a surprisingly heterogeneous
outcome. We searched for known factors contributing to this
variable virulence. Most clinical S. aureus isolates have sero-
type 5 (CP5) or serotype 8 (CP8) capsules. By comparing the
biological activities of isogenic mutants with CP5, CP8, or no
capsule in a mouse model, Watts et al. showed that CP5-
positive strains were more virulent than both CP8-positive
strains and CP-negative strains (24). We did not find a corre-
lation between CP5 positivity and mouse lethality in our study,
which may well be due to other confounding factors in the
clonal strains.
MRSA ST8 isolates shared the sea gene and produced SEA
in vitro, and MRSA ST5 isolates shared the tst gene and pro-
duced TSST-1 in vitro. Previously, we assumed that SEA was
involved in the pathogenesis of S. aureus septic shock, since we
detected sea more frequently in blood isolates from patients
with septic shock than in isolates from patients without septic
shock (12). The sea and tst genes have been detected in several
pandemic MRSA clones (CC8 and CC30 and CC5 and CC30,
respectively) (11). Recently, Diep et al. demonstrated that
horizontal transfer of virulence genes such as sea and tst was
epidemiologically associated with the emergence of new viru-
lent strains of both hospital- and community-acquired MRSA
(8). However, mice are less susceptible than humans to super-
antigenic toxins, and D-galactosamine administration, which
enhances mouse susceptibility to these toxins, was not used in
our study. Finally, among the sea-positive clonal MRSA iso-
lates tested here, three ST8 isolates were nonlethal for mice.
Thus, CP5 expression and SEA or TSST-1 production were not
sufficient to induce mortality in mice and other still unknown
virulence factors may be involved in the pathogenesis of sepsis
induced by ST8 and ST5 MRSA clones. This conclusion is
supported by our observation that deletion of tst in an MRSA
ST5 strain enhanced, rather than reduced, its virulence. This in
FIG. 4. Individual genotypic and phenotypic characteristics of the MRSA and MSSA ST5 isolates.
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turn supports the putative role of tst as a negative global reg-
ulator of other exoproteins, as shown by Vojtov et al. (23).
However, our conclusions are not restricted to observations
made in one mouse strain; mortality induced with the MRSA
ST8 clones was similarly variable in the more susceptible
BALB/c strain, where strains that are avirulent in C57BL/6
mice remained weakly virulent.
In summary, SCCmec type IVA in the ST8 background was
associated with decreased virulence, while conversely SCCmec
type IV in the ST5 background was associated with increased
virulence. Thus, the effect of the SCCmec cassette on pheno-
typic characteristics may depend on the genetic background of
the strains and heterogeneity may be linked not only to one
specific virulence factor, but to differences in global regulation
or to single nucleotide polymorphisms, pathogenicity islands,
and endogeneous phages, not detected in our study. Whole-
genome sequencing of the clonal isolates with different out-
comes will facilitate identification of hitherto unknown genes
responsible for high virulence.
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